Harry Boxer’s stocks to watch include maker of Botox competitor
February 08, 2019 at 15:11 PM EST
Evolus received FDA approval for a treatment for frown lines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|